RRoche Read More CytomX Adds Fuchs With 3+ Decades in Oncology to Board2026-07-27 CytomX Therapeutics (Nasdaq: CTMX) has appointed Charles Fuchs, M.D., M.P.H., a board-certified medical oncologist with…